Skip to main content
S2033AMedical Services

Businesses and Professions - Protections of Healthcare Providers Act

This bill allows healthcare providers prescribing abortion medications to put their practice's name on the label instead of their own.

Introduced33 Yea5 Nay0 Not voting
Population
Affected
15
Introduced Jan 9, 2026Committee Senate Health & Human Services

Plain-English Summary

This bill changes the rules for prescription labels on medication abortion drugs, such as mifepristone and misoprostol. It allows the healthcare provider who prescribes these medications to ask that the name of their medical practice be printed on the prescription label instead of their own personal name.

For younger readers

When you get medicine from a pharmacy, the bottle usually has the name of the doctor who gave it to you printed on the sticker. This bill changes the rules for a specific kind of medicine used to end a pregnancy. It says that the doctor who gives this medicine can ask the pharmacy to print the name of the doctor's office on the sticker instead of the doctor's actual name.

Who & Where It Applies

Impacted groups
Healthcare providersPharmacistsPatients seeking abortionsMedical practices
Impacted communities
All

Constitutional & Fiscal Check

None Likely. This bill regulates prescription labeling for safety and privacy reasons and does not appear to infringe on free speech, due process, or protection from unreasonable searches and seizures.

Estimated cost
None
Estimated revenue
None

Bill Analysis

Both viewpoints
For Progressives
  • Protects the privacy and physical safety of healthcare providers who prescribe abortion medications by shielding their personal names from prescription labels, reducing the risk of targeted harassment or violence.
  • Helps maintain and potentially increase access to reproductive healthcare by making providers feel safer and more willing to offer medication abortion services in their communities.
  • Supports bodily autonomy and reproductive justice by safeguarding the infrastructure and personnel necessary for individuals to safely and confidentially access abortion care.
  • Only applies to providers of medication abortion, missing an opportunity to extend similar privacy protections to providers of other targeted services, such as gender-affirming care.
  • Places the burden on the prescriber to actively request the name substitution, rather than making it an automatic default to ensure maximum protection for all providers.
  • Focuses solely on the provider and does not include provisions to enhance the privacy or safety of the patients receiving the medication, whose personal information remains on the label.
For Conservatives
  • Enhances the branding and visibility of private healthcare practices by allowing the corporate or business name to be placed on prescription labels instead of an individual employee's name.
  • Reduces strict government mandates on how private medical businesses must label their products, offering more flexibility in how they operate their practices.
  • Creates a voluntary, opt-in mechanism rather than a sweeping government mandate, allowing individual prescribers to choose whether or not to utilize the provision.
  • Facilitates and protects the practice of medication abortions, which directly conflicts with traditional social values and the conservative goal of restricting or banning abortion access.
  • Reduces transparency and personal accountability by allowing individual doctors who prescribe abortion drugs to hide their personal identities behind a corporate practice name.
  • Could make it more difficult for law enforcement or regulatory bodies to quickly identify the specific individual responsible for prescribing the medication if complications or legal issues arise.

Votes

Loading votes...

Full Bill Text

2 versions
Changes to existing Rhode Island law · 7 additions

SECTION 1. Chapter 5-37.8 of the General Laws entitled "Protections for Healthcare Providers Act" is hereby amended by adding thereto the following section: 5-37.8-4. Prescriptive protections for providers of legal protected healthcare activity.

(a) Notwithstanding any other provision in this chapter to the contrary, at the prescriber's request, the prescription label for medication abortion prescription drugs may include the name of the prescriber's healthcare practice instead of the name of the prescriber.

(b) For purposes of this section, “medication abortion prescription drugs” means substances used in the course of medical treatment intended to induce the termination of a pregnancy including, but not limited to, mifepristone and misoprostol.

SECTION 2. This act shall take effect upon passage.